Skip to content

Transformation Research and Development of Qingchang Tongru Granules Combined with Xiaoyanghe Ointment for the Treatment of Lactational Mastitis in Medical Institutions

Transformation Research and Development of Qingchang Tongru Granules Combined with Xiaoyanghe Ointment for the Treatment of Lactational Mastitis in Medical Institutions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000013
Enrollment
Unknown
Registered
2025-01-03
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute mastitis

Interventions

Control group:
Experimental group:Qingchang Tongru Granules and the external use formula of Xiaoyanghe Ointment

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medical UniversityHangzhou Zhejiang
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1) Age =18 years old; 2) Patients diagnosed as acute mastitis in the early stage of lactation (Western medicine: milk stasis or acute inflammation type/Chinese medicine: liver and stomach stagnation heat type or heat toxin incandescent syndrome of breast has not yet become pus); 3) Willingness to continue breastfeeding; 4) Willing to accept the test and sign the informed consent;

Exclusion criteria

Exclusion criteria: 1) The formation of breast abscess or has been festering or stiff lump stage; 2) combined with breast cancer; 3)No desire to breastfeed; 4) Patients with chronic infectious diseases requiring antibiotic treatment; 5) accompanied by serious heart liver kidney and other organic dysfunction or mental illness; 6)4 weeks before enrollment or during the study period antibiotics and probiotics were used;

Design outcomes

Primary

MeasureTime frame
Clinical cure rate;Mastitis symptoms and signs;

Secondary

MeasureTime frame
Determination OF BACTERIAL FLORA;Suppuration rate of breast lump;Blood inflammatory markers;Metabolomics;

Countries

China

Contacts

Public ContactXiufei Gao

The First Affiliated Hospital of Zhejiang Chinese Medical UniversityHangzhou Zhejiang

gaoxiufei@zcmu.edu.cn13868186611

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026